Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France

Neurosurgical Review

Volumn 37, Issue 3, 2014, Pages 415-423

  Zouaoui, Sonia ^a   Darlix, Amélie ^b   Fabbro Peray, Pascale ^c,m   Mathieu Daudé, Hélène ^d   Rigau, Valérie ^e   Fabbro, Michel ^b   Bessaoud, Faiza ^d   Taillandier, Luc ^f   Ducray, François ^g   Bauchet, Fabienne ^d   Wager, Michel ^f   Faillot, Thierry ^h   Capelle, Laurent ⁱ   Loiseau, Hugues ^j   Kerr, Christine ^b   Menei, Philippe ^k   Duffau, Hugues ^a   Figarella Branger, Dominique ^l   Chinot, Olivier ^l   Trétarre, Brigitte ^d   Bauchet, Luc ^a   more..

^a HÔPITAL SAINT ELOI   (France)

^b CENTRE VAL D AURELLE   (France)

^c UNIV MONTPELLIER   (France)

^d Department of Epidemiology   (France)

^e GUI DE CHAULIAC HOSPITAL   (France)

^f POITIERS UNIVERSITY HOSPITAL   (France)

^g HÔPITAL NEUROLOGIQUE   (France)

^h BEAUJON HOSPITAL   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j HÔPITAL PELLEGRIN   (France)

^k ANGERS UNIVERSITY HOSPITAL   (France)

^l TIMONE HOSPITAL   (France)

^m NÎMES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Database; Elderly; Glioblastoma; Neurooncology; Neurosurgery

Indexed keywords

TEMOZOLOMIDE;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHEMORADIOTHERAPY; CONTROLLED STUDY; ELDERLY CARE; FEMALE; FRANCE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SURVIVAL PREDICTION; SURVIVAL TIME; TUMOR BIOPSY; BIOPSY; BRAIN NEOPLASMS; MORTALITY; MULTIMODALITY CANCER THERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOPSY; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FRANCE; GLIOBLASTOMA; HUMANS; MALE; PATIENT CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84904671228     PISSN: 03445607     EISSN: 14372320     Source Type: Journal    
DOI: 10.1007/s10143-014-0528-8     Document Type: Article

References (36)

1. Barker CA, Chang M, Chou JF, Zhang Z, Beal K, Gutin PH, Iwamoto FM (2012) Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J Neurooncol 109:391-397. doi:10.1007/s11060-012- 0906-4
2. Barnholtz-Sloan JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, Chamberlain M, Sloan AE (2008) Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 108:642-648. doi:10.3171/jns/2008/108/4/0642 (Pubitemid 351498955)
3. Bauchet L, Mathieu-Daude H, Fabbro-Peray P, Rigau V, Fabbro M, Chinot O, Pallusseau L, Carnin C, Laine K, Schlama A, Thiebaut A, Patru MC, Bauchet F, Lionnet M, Wager M, Faillot T, Taillandier L, Figarella-Branger D, Capelle L, Loiseau H, Frappaz D, Campello C, Kerr C, Duffau H, Reme-Saumon M, Tretarre B, Daures JP, Henin D, Labrousse F, Menei P, Honnorat J (2010) Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol 12:725-735. doi:10.1093/neuonc/noq030
4. Bauchet L, Rigau V, Mathieu-Daudé H, Fabbro-Peray P, Palenzuela G, Figarella-Branger D, Moritz J, Puget S, Bauchet F, Pallusseau L, Duffau H, Coubes P, Trétarre B, Labrousse F, Dhellemmes P (2009) Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol 92:87-98. doi:10.1007/s11060-008-9740-0
5. Bauchet L, Rigau V, Mathieu-Daudé H, Figarella-Branger D, Hugues D, Palusseau L, Bauchet F, Fabbro M, Campello C, Capelle L, Durand A, Trétarre B, Frappaz D, Henin D, Menei P, Honnorat J, Segnarbieux F (2007) French brain tumor data bank: Methodology and first results on 10,000 cases. J Neurooncol 84:189-199. doi:10.1007/s11060-007-9356-9 (Pubitemid 47202129)
6. Brandes AA, Franceschi E, Tosoni A, Benevento F, Scopece L, Mazzocchi V, Bacci A, Agati R, Calbucci F, Ermani M (2009) Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma. Cancer 115:3512-3518. doi:10.1002/cncr.24406
7. Central Brain Tumor Registry of the United States (CBTRUS) CBTRUS 2012 Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008 http://www.cbtrus.org/2012-NPCR-SEER/CBTRUS- Report-2004-2008-3-23-2012.pdf. Revised March 23, 2012. Accessed 06 Nov 2012
8. Chargari C, Feuvret L, Bauduceau O, Ricard D, Cuenca X, Delattre J-Y, Mazeron J-J (2012) Treatment of elderly patients with glioblastoma: from clinical evidence to molecular highlights. Cancer Treat Rev 38:988-995. doi:10.1016/j.ctrv.2011.12.010
9. Davis FG, Malmer BS, Aldape K, Barnholtz-Sloan JS, Bondy ML, Brännström T, Bruner JM, Burger PC, Collins VP, Inskip PD, Kruchko C, McCarthy BJ, McLendon RE, Sadetzki S, Tihan T, Wrensch MR, Buffler PA (2008) Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomark Prev 17:484-489. doi:10.1158/1055-9965.epi-07-0725 (Pubitemid 351469196)
10. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14(suppl 5):v1-v49. doi:10.1093/neuonc/nos218
11. Gállego Perez-Larraya J, Ducray F, Chinot O, Catry-Thomas I, Taillandier L, Guillamo JS, Campello C, Monjour A, Cartalat-Carel S, Barrie M, Huchet A, Beauchesne P, Matta M, Mokhtari K, Tanguy ML, Honnorat J, Delattre JY (2011) Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. J Clin Oncol 29:3050-3055. doi: 10.1200/jco.2011.34.8086
12. Graus F, Bruna J, Pardo J, Escudero D, Vilas D, Barceló I, Brell M, Pascual C, Crespo JA, Erro E, García-Romero JC, Estela J, Martino J, García-Castaño A, Mata E, Lema M, Gelabert M, Fuentes R, Pérez P, Manzano A, Aguas J, Belenguer A, Simón A, Henríquez I, Murcia M, Vivanco R, Rojas-Marcos I, Muñoz-Carmona D, Navas I, de Andrés P, Mas G, Gil M, Verger E (2013) Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain. Neuro Oncol [Epub ahead of print]
13. Gulati S, Jakola AS, Johannesen TB, Solheim O (2012) Survival and Treatment Patterns of glioblastoma in the elderly: a population-based study. World Neurosurg 78:518-526. doi:10.1016/j.wneu.2011.12.008
14. Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JEC, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003. doi:10.1056/ NEJMoa043331 (Pubitemid 40349502)
15. Iwamoto FM, Cooper AR, Reiner AS, Nayak L, Abrey LE (2009) Glioblastoma in the elderly. Cancer 115:3758-3766. doi:10.1002/cncr.24413
16. Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64:628-634. doi:10.1002/ana.21521
17. Johnson DR, O'Neill BP (2012) Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol 107: 359-364. doi:10.1007/s11060-011-0749-4
18. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, Guillamo J-S, Jadaud E, Colin P, Bondiau P-Y, Meneï P, Loiseau H, Bernier V, Honnorat J, Barrié M, Mokhtari K, Mazeron J-J, Bissery A, Delattre J-Y (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527-1535. doi:10.1056/NEJMoa065901 (Pubitemid 46588417)
19. Kleihues P, Cavenee WK (2000) Tumours of the nervous system, pathology and genetics classification of tumours. International Agency for Research on Cancer Press, Lyon
20. Koshy M, Villano JL, Dolecek TA, Howard A, Mahmood U, Chmura SJ, Weichselbaum RR, McCarthy BJ (2011) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107:207-212. doi:10.1007/s11060-011-0738-7
21. Malmström A, Grønberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermitte B, Hegi ME, Rosell J, Henriksson R (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13:916-926. doi:10.1016/s1470-2045(12) 70265-6
22. Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, Arcella A, De Sanctis V, Giangaspero F, Enrici RM (2012) Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 83:93-99. doi:10.1016/j.ijrobp.2011. 06.1992
23. Reardon DA (2012) Treatment of elderly patients with glioblastoma. Lancet Oncol 13:656-657. doi:10.1016/S1470-2045(12)70186-9
24. Reyngold M, Lassman A, Chan T, Yamada Y, Gutin P, Beal K (2012) Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status. J Neurooncol 110:369-374. doi:10.1007/s11060-012-0972-7
25. Rigau V, Zouaoui S, Mathieu-Daudé H, Darlix A, Maran A, Trétarre B, Bessaoud F, Bauchet F, Attaoua R, Fabbro-Peray P, Fabbro M, Kerr C, Taillandier L, Duffau H, Figarella-Branger D, Costes V, Bauchet L (2011) French Brain Tumor DataBase: 5-Year histological results on 25 756 cases. Brain Pathol 21:633-644. doi:10.1111/j.1750-3639.2011.00491.x
26. Rønning PA, Helseth E, Meling TR, Johannesen TB (2012) A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. Neuro Oncol 14:1178-1184. doi: 10.1093/neuonc/nos153
27. Scott J, Tsai Y-Y, Chinnaiyan P, Yu H-HM (2011) Effectiveness of radiotherapy for elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 81:206-210. doi:10.1016/j.ijrobp.2010.04.033
28. Scott JG, Bauchet L, Fraum TJ, Nayak L, Cooper AR, Chao ST, Suh JH, Vogelbaum MA, Peereboom DM, Zouaoui S, Mathieu-Daudé H, Fabbro-Peray P, Rigau V, Taillandier L, Abrey LE, DeAngelis LM, Shih JH, Iwamoto FM (2012) Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer 118:5595-5600. doi:10.1002/cncr.27570
29. Scott JG, Suh JH, Elson P, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GHJ, Elinzano H, Chao ST (2011) Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol 13:428-436. doi:10.1093/neuonc/nor005
30. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401. doi:10.1016/S1470-2045(06)70665-9
31. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996. doi:10.1056/NEJMoa043330 (Pubitemid 40349501)
32. Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J (2003) Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien) 145:5-10. doi:10.1007/s00701-002-1030-6 (Pubitemid 36174074)
33. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79-88, 10.1215/S1522-8517-02-00023-6 (Pubitemid 36422560)
34. Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M, NOASGotN-oWGotGCS (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707-715. doi:10.1016/s1470-2045(12) 70164-x
35. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278-299. doi:10.1093/neuonc/4.4.278
36. Zouaoui S, Rigau V, Mathieu-Daudé H, Darlix A, Bessaoud F, Fabbro-Peray P, Bauchet F, Kerr C, Fabbro M, Figarella-Branger D, Taillandier L, Duffau H, Trétarre B, Bauchet L (2012) Recensement national histologique des tumeurs primitives du système nerveux central : résultats généraux sur 40 000 cas, principales applications actuelles et perspectives. Neurochirurgie 58:4-13. doi:10.1016/j.neuchi.2012.01.004